Cargando…
Additional neoadjuvant immunotherapy does not increase the risk of anastomotic leakage after esophagectomy for esophageal squamous cell carcinoma: a multicenter retrospective cohort study
PURPOSE: Neoadjuvant chemoimmunotherapy (nICT) is a novel and promising therapy model for locally advanced esophageal squamous cell carcinoma.The objective of this study aimed to assessed the impact of additional neoadjuvant immunotherapy on patients’ short-term outcomes, particularly the incidence...
Autores principales: | Hong, Zhinuan, Xu, Jinxin, Chen, Zhen, Xu, Hui, Huang, Zhixin, Weng, Kai, Cai, Junlan, Ke, Sunkui, Chen, Shuchen, Xie, Jinbiao, Duan, Hongbing, Kang, Mingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442078/ https://www.ncbi.nlm.nih.gov/pubmed/37318861 http://dx.doi.org/10.1097/JS9.0000000000000487 |
Ejemplares similares
-
Development of nomograms predictive of anastomotic leakage in patients before minimally invasive McKeown esophagectomy
por: Chen, Jianqing, et al.
Publicado: (2023) -
Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment
por: Fabbi, M, et al.
Publicado: (2020) -
Anastomotic reinforcement with omentoplasty reduces anastomotic leakage for minimally invasive esophagectomy with cervical anastomosis
por: Zhou, Dong, et al.
Publicado: (2018) -
Development and validation of a nomogram to predict anastomotic leakage after esophagectomy for esophageal carcinoma
por: Yu, Wen-Quan, et al.
Publicado: (2021) -
Impact of intravenous injection of glucagon on anastomotic leakage in esophagectomy
por: Kita, Ryosuke, et al.
Publicado: (2023)